Help us reach our family's $1,000 goal!
Meet Olivia
Olivia was diagnosed with creatinine transporter deficiency when she was 10 years old. CTD has impacted her life in many ways. Despite the obstacles you can still see the bright, kind person she is.
A cure would be amazing to see. While I fear that a cure will come too late to help Olivia, I dream of other kids like Olivia having a shot at a more typical development path.
Since 2012, ACD has led the fight against creatine deficiencies. With 100% of Holiday Heroes donations being directed to research, your participation in this campaign is crucial in helping ACD continue that fight. Thank you for your support.
Your Holiday Heroes Donation Supports Research
UC Berkeley
1-year research award to accelerate the development of a novel method to deliver a key enzyme directly into cells to enable creatine production in individuals with GAMT deficiency.
Johns Hopkins University
2-year research investment to accelerate their work to deliver creatine to the brain, including to neurons, using dendrimer nanoparticles, without the need of a creatine transporter, to help patients with CTD.
Stanford University
2-year research award to build upon their work developing new ways to deliver creatine directly into cells without relying on the faulty transporter protein that causes CTD.
Ultragenyx
Investment in the clinical development of an investigational therapy for Creatine Transporter Deficiency (CTD) with a total commitment of $4 million as the program progresses.
Research Fellowship
Help us award our 6th year of research fellowships supporting 12 months of CCDS research for young researchers establishing their careers.
CTD Newborn Screening Research
Support assay development for CTD newborn screening technology enabling advocacy for early diagnosis of Creatine Transporter Deficiency.
